Carl Swanson’s Post

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉 https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

🚀 Elevate Your Knowledge: Join our webinar "Considerations for Navigating ISO 22442-3 Viral Inactivation Studies" Delve into the intricacies of medical devices using preclinical model tissues and their derivatives with NAMSA's experts! Key Discussion Points: - Various applications of preclinical model tissues in medical devices - The critical need for viral inactivation testing - Customizing studies and overcoming associated challenges - Molecular screening and batch release considerations Don't miss out on crucial insights! Save your spot now. 📆👉https://lnkd.in/emn6wQfN #MedicalDevices #ISO22442 #ViralInactivation #RegulatoryCompliance #NAMSAknows

Are you involved in the medical device sector? Want to stay ahead of the curve with the latest regulatory updates? Then don't miss our upcoming webinar. Industry experts will delve into the recent extensions to the In Vitro Diagnostic Regulation (IVDR) and what they mean for you. Speakers: Dr. Julien Senac, Ph.D., Sue Spencer, and Erik Vollebregt #IVDR #webinar LGC Biosearch Technologies

We think "functional QC" can be a key tool to enhance confidence in advanced in vitro disease models. But what is functional QC (fQC)? How could it be applied to iPSC technology? And why are we striving to incorporate fQC in our cell manufacturing? We discuss this in our latest thought piece, where we discuss the role of fQC in producing useful, functional cells that can fuel advanced in vitro models with enhanced translational power. Click here to learn more about it and download the thought piece: https://hubs.la/Q02l9bLs0 P.S., We're hosting our first webinar of the year on the 28th February (4pm GMT), entitled "QC, Functional QC & iPSCs: the importance in better human disease modeling". Click here to register: https://hubs.la/Q02l9gJ50 #iPSCs #ISO9001 #StemCells #functionalQC #DrugDiscovery

#ICYMI ➡️ We announced the latest findings from a new, in vitro study showing a significant reduction in bacterial adhesion in peripherally inserted central catheters (PICC) and midline catheters with our MIMIX™ hydrophilic biomaterial (HBM) versus standard polyurethane. Check out the study details in the press release here: https://loom.ly/PvGbx5g #AVINews #TransformingVascularAccess #Medtech *Data on file at Access Vascular. Reduction of thrombus accumulation was evaluated using in vitro and in vivo models. Pre-clinical in vitro/in vivo evaluations do not necessarily predict clinical performance with respect to thrombus formation.

"When we started looking at pharmacogenetics a few years ago, it was cutting-edge technology. I think more and more we are starting to see this as a standard of care," said Dr. Joel Diamond.   Aranscia's Dr. Joel Diamond spoke with HIMSS TV to discuss the progression of precision medicine since his last interview at HIMSS 2022 and how molecular diagnostics is working to improve patient outcomes.   Click the link below to watch "Digital Checkup with Andrea Fox featuring Joel Diamond, MD, CMO at Aranscia." https://lnkd.in/e4q_axU9 #precisionmedicine #precisiondiagnostics #HIMSSTV #DigitalCheckup #DrJoelDiamond #pharmacogenomics #PGx #precisiononcology #medicationstewardship #moleculardiagnostics #adversedrugevents

Attending #MSACL2024 in Monterey?! Make sure you stop by booth #21 to learn how SCIEX's LC-MS/MS solutions can help you advance your work in #clinical research and diagnostics. And make sure to check out our posters in the Exhibit Hall (Serra) showcasing the latest clinical applications. #ClinicalAnalysis #InnovationMatters #EducationMatters SCIEX is presenting 3 posters on the following topics: -High-resolution mass spectrometry peptide quantitation for biomarker verification with limited method development (Poster #10b) -Quantitative and qualitative analysis of steroids with simplified sample preparation (Poster #4a) -Development of highly sensitive analytical techniques for the detection of galactosylsphingosine (GalSPH) and glucosylsphingosine (GluSPH) in cerebral spinal fluid (Poster #4b) Advance your clinical knowledge with our posters from MSACL 2024! https://bit.ly/4a4Axx0